Quantum Molecular Resonance Effects on Patients With Dry Eye Disease
Dry Eye Syndromes
About this trial
This is an interventional treatment trial for Dry Eye Syndromes focused on measuring Cornea, Dry Eye, Quantum Molecular Resonance
Eligibility Criteria
Inclusion Criteria:
- Patients above the age of 18 years
- Patients who are willing and able to consent and adhere to the research plan
- Patients diagnosed with dry eye or patients who are at risk for dry eye
Exclusion Criteria:
- Active infection of the eyelid or periorbital area
- Patients who are pregnant or lactating
- Patients under the age of 18
- Those scheduled for (<30 days) or immediately after (<30 days) ocular surgery (excluding cataract and eyelid surgery)
- Patient who do not adhere to all four treatment sessions.
Sites / Locations
- Shamir Medical CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Treatment
Placebo
Pre-treatment medical examination by an ophthalmologist and self-filled questionnaire. Four treatment sessions. Each session includes 20 minutes with the instrument active at power level 4. Post-treatment medical examination by an ophthalmologist and self-filled questionnaire.
Pre-treatment medical examination by an ophthalmologist and self-filled questionnaire. Four treatment sessions. Each session includes 20 minutes with the instrument active at power level 0. Post-treatment medical examination by an ophthalmologist and self-filled questionnaire.